맞춤형 유전자 치료 시장 보고서(2026년)

Personalized gene therapy treatment is a specialized medical approach that provides therapies specifically designed according to an individual's distinct genetic makeup. It alters, corrects, or substitutes defective genes to directly target the root causes of genetic disorders. Personalized gene therapy treatment improves treatment accuracy, reduces side effects, and increases therapeutic efficacy.

The primary categories of personalized gene therapy treatments include targeted therapies and pharmacogenomics. Targeted therapies are developed to specifically modify or regulate certain genes linked to a disease, aiming to provide optimal therapeutic benefits while minimizing side effects. The vectors used can be viral or non-viral, and these therapies are delivered through various channels, including hospitals, clinics, home administration, and others, for applications across multiple medical specialties such as oncology, neurology, hematology, infectious diseases, ophthalmology, and more.

Tariffs are impacting the personalized gene therapy treatment market by increasing costs of imported viral vectors, laboratory reagents, bioprocessing equipment, and advanced genetic sequencing tools required for therapy development and delivery. North America and Europe are most affected due to reliance on cross-border sourcing of specialized biologics and manufacturing inputs, while Asia-Pacific faces higher costs for advanced research infrastructure. These tariffs are raising development and treatment costs and extending commercialization timelines. However, they are also encouraging localized manufacturing, regional supply chain development, and increased domestic investment in gene therapy production capabilities.

The personalized gene therapy treatment market research report is one of a series of new reports from The Business Research Company that provides personalized gene therapy treatment market statistics, including personalized gene therapy treatment industry global market size, regional shares, competitors with a personalized gene therapy treatment market share, detailed personalized gene therapy treatment market segments, market trends and opportunities, and any further data you may need to thrive in the personalized gene therapy treatment industry. This personalized gene therapy treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The personalized gene therapy treatment market size has grown exponentially in recent years. It will grow from $8.38 billion in 2025 to $10.11 billion in 2026 at a compound annual growth rate (CAGR) of 20.7%. The growth in the historic period can be attributed to increasing prevalence of genetic disorders, advancements in genomic sequencing technologies, early clinical success of targeted gene therapies, expansion of specialized gene therapy research centers, increasing investment in precision medicine.

The personalized gene therapy treatment market size is expected to see exponential growth in the next few years. It will grow to $21.23 billion in 2030 at a compound annual growth rate (CAGR) of 20.4%. The growth in the forecast period can be attributed to increasing regulatory approvals for personalized gene therapies, rising demand for customized oncology treatments, expansion of gene therapy manufacturing capabilities, growing integration of AI in therapy design, increasing adoption of pharmacogenomics-guided treatments. Major trends in the forecast period include increasing adoption of gene editing-based therapies, rising use of personalized treatment protocols, growing integration of companion diagnostics, expansion of viral and non-viral vector platforms, enhanced focus on precision oncology applications.

The rising prevalence of genetic disorders is expected to drive the growth of the personalized gene therapy treatment market in the coming years. Genetic disorders are conditions caused by abnormalities in DNA that interfere with normal body functions. The prevalence of genetic disorders is increasing due to advancing parental age, as older reproductive cells carry a higher risk of mutations that can be inherited by offspring. Personalized gene therapy targets genetic disorders by accurately correcting the defective genes responsible for the condition and customizing treatment according to an individual's genetic profile, improving effectiveness and minimizing side effects. For example, in October 2024, according to the Cystic Fibrosis Trust, a UK-based charity supporting individuals with cystic fibrosis, approximately 11,148 cystic fibrosis patients were registered in 2022, and this number rose to 11,318 in 2023, representing a 1.5% year-over-year increase in patient registrations. Therefore, the rising prevalence of genetic disorders is fueling the growth of the personalized gene therapy treatment market.

Major companies operating in the personalized gene therapy treatment market are concentrating on forming strategic partnerships to enhance technological capabilities and deliver innovative therapies to patients more efficiently. Strategic partnerships are collaborative alliances between organizations that utilize each other's strengths and resources for mutual growth and competitive advantage while sharing risks and benefits. For example, in May 2025, Aldevron, a US-based company specializing in the production of DNA, RNA, and proteins, partnered with Integrated DNA Technologies, a US-based provider of genomics solutions, to produce the world's first mRNA-based personalized CRISPR therapy for an infant with a rare and life-threatening genetic disorder, urea cycle disorder (UCD). This N of 1 therapy was developed and administered in just six months by designing a custom guide RNA, an mRNA-encoded base editor, off-target safety services, and a clinically validated lipid nanoparticle delivery system. The development of this therapy represents a significant milestone in personalized in vivo base-editing treatments.

In July 2025, Eli Lilly and Company, a US-based pharmaceutical firm, acquired Verve Therapeutics, Inc. for $1.3 billion. Through this acquisition, Eli Lilly aims to broaden its portfolio into cardiovascular gene-editing therapies and enhance its position in the personalized gene therapy sector. Verve Therapeutics is a US-based clinical-stage company developing one-time base-editing gene therapies specifically targeting cardiovascular disease.

Major companies operating in the personalized gene therapy treatment market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

North America was the largest region in the personalized gene therapy treatment market in 2025. The regions covered in the personalized gene therapy treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized gene therapy treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized gene therapy treatment market consists of revenues earned by entities by providing services such as genetic testing and diagnostics, personalized therapy design, gene editing treatments, viral and non-viral vector delivery, patient-specific cell therapies, and post-treatment monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized gene therapy treatment market also includes sales of viral vectors, gene editing platforms, cell culture systems, bioprocessing tools, and monitoring software. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Gene Therapy Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses personalized gene therapy treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized gene therapy treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The personalized gene therapy treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Therapy: Targeted Treatments; Pharmacogenomics
• 2) By Vector Type: Viral; Non-Viral
• 3) By Distribution Channel: Hospitals; Clinics; Home Administration; Other Distribution Channels
• 4) By Application: Oncology; Neurology; Hematological; Infectious Diseases; Ophthalmology; Other Applications
• Subsegments:
• 1) By Targeted Treatments: Monoclonal Antibodies; Chimeric Antigen Receptor T-Cell Therapy (CAR-T); Small Interfering RNA (siRNA) Therapy; Antisense Oligonucleotides (ASO); Gene Editing Therapy
• 2) By Pharmacogenomics: Companion Diagnostics; Drug Metabolism Enzyme Testing; Genetic Biomarker Analysis; Single Nucleotide Polymorphism (SNP) Profiling; Adverse Drug Reaction (ADR) Prediction
• Companies Mentioned: Thermo Fisher Scientific Inc.; Illumina Inc.; Myriad Genetics Inc.; BGI Genomics Co. Ltd.; Invitae Corporation; Guardant Health Inc.; GeneDx LLC; Ancestry Inc.; Oxford Nanopore Technologies plc; Genomic Health Inc.; 23andMe Holding Co.; Color Health Inc.; Helix OpCo LLC; Personalis Inc.; Dante Genomics; Gene By Gene Ltd.; Veritas Genetics Inc.; Futura Genetics; Nebula Genomics Inc.; Pathway Genomics Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Personalized Gene Therapy Treatment Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Personalized Gene Therapy Treatment Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Personalized Gene Therapy Treatment Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Personalized Gene Therapy Treatment Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Gene Editing-Based Therapies
  • 4.2.2 Rising Use Of Personalized Treatment Protocols
  • 4.2.3 Growing Integration Of Companion Diagnostics
  • 4.2.4 Expansion Of Viral And Non-Viral Vector Platforms
  • 4.2.5 Enhanced Focus On Precision Oncology Applications

5. Personalized Gene Therapy Treatment Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Clinics
• 5.3 Research Institutes
• 5.4 Biotechnology Companies
• 5.5 Oncology Treatment Centers

6. Personalized Gene Therapy Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Personalized Gene Therapy Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Personalized Gene Therapy Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Personalized Gene Therapy Treatment Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Personalized Gene Therapy Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Personalized Gene Therapy Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Personalized Gene Therapy Treatment Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Personalized Gene Therapy Treatment Market Segmentation

• 9.1. Global Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Targeted Treatments, Pharmacogenomics
• 9.2. Global Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Viral, Non-Viral
• 9.3. Global Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Home Administration, Other Distribution Channels
• 9.4. Global Personalized Gene Therapy Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Neurology, Hematological, Infectious Diseases, Ophthalmology, Other Applications
• 9.5. Global Personalized Gene Therapy Treatment Market, Sub-Segmentation Of Targeted Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Monoclonal Antibodies, Chimeric Antigen Receptor T-Cell Therapy (CAR-T), Small Interfering RNA (siRNA) Therapy, Antisense Oligonucleotides (ASO), Gene Editing Therapy
• 9.6. Global Personalized Gene Therapy Treatment Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Companion Diagnostics, Drug Metabolism Enzyme Testing, Genetic Biomarker Analysis, Single Nucleotide Polymorphism (SNP) Profiling, Adverse Drug Reaction (ADR) Prediction

10. Personalized Gene Therapy Treatment Market Regional And Country Analysis

• 10.1. Global Personalized Gene Therapy Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Personalized Gene Therapy Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Personalized Gene Therapy Treatment Market

• 11.1. Asia-Pacific Personalized Gene Therapy Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Personalized Gene Therapy Treatment Market

• 12.1. China Personalized Gene Therapy Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Personalized Gene Therapy Treatment Market

• 13.1. India Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Personalized Gene Therapy Treatment Market

• 14.1. Japan Personalized Gene Therapy Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Personalized Gene Therapy Treatment Market

• 15.1. Australia Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Personalized Gene Therapy Treatment Market

• 16.1. Indonesia Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Personalized Gene Therapy Treatment Market

• 17.1. South Korea Personalized Gene Therapy Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Personalized Gene Therapy Treatment Market

• 18.1. Taiwan Personalized Gene Therapy Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Personalized Gene Therapy Treatment Market

• 19.1. South East Asia Personalized Gene Therapy Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Personalized Gene Therapy Treatment Market

• 20.1. Western Europe Personalized Gene Therapy Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Personalized Gene Therapy Treatment Market

• 21.1. UK Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Personalized Gene Therapy Treatment Market

• 22.1. Germany Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Personalized Gene Therapy Treatment Market

• 23.1. France Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Personalized Gene Therapy Treatment Market

• 24.1. Italy Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Personalized Gene Therapy Treatment Market

• 25.1. Spain Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Personalized Gene Therapy Treatment Market

• 26.1. Eastern Europe Personalized Gene Therapy Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Personalized Gene Therapy Treatment Market

• 27.1. Russia Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Personalized Gene Therapy Treatment Market

• 28.1. North America Personalized Gene Therapy Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Personalized Gene Therapy Treatment Market

• 29.1. USA Personalized Gene Therapy Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Personalized Gene Therapy Treatment Market

• 30.1. Canada Personalized Gene Therapy Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Personalized Gene Therapy Treatment Market

• 31.1. South America Personalized Gene Therapy Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Personalized Gene Therapy Treatment Market

• 32.1. Brazil Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Personalized Gene Therapy Treatment Market

• 33.1. Middle East Personalized Gene Therapy Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Personalized Gene Therapy Treatment Market

• 34.1. Africa Personalized Gene Therapy Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Segmentation By Vector Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Personalized Gene Therapy Treatment Market Regulatory and Investment Landscape

36. Personalized Gene Therapy Treatment Market Competitive Landscape And Company Profiles

• 36.1. Personalized Gene Therapy Treatment Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Personalized Gene Therapy Treatment Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Personalized Gene Therapy Treatment Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Myriad Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. BGI Genomics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Personalized Gene Therapy Treatment Market Other Major And Innovative Companies

• Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

38. Global Personalized Gene Therapy Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Personalized Gene Therapy Treatment Market

40. Personalized Gene Therapy Treatment Market High Potential Countries, Segments and Strategies

• 40.1 Personalized Gene Therapy Treatment Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Personalized Gene Therapy Treatment Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Personalized Gene Therapy Treatment Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer